PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,629,073 | -55.3% | 72,694 | -18.8% | 0.00% | -50.0% |
| Q2 2023 | $3,640,981 | +15.2% | 89,525 | +37.2% | 0.00% | +33.3% |
| Q1 2023 | $3,160,710 | +35.3% | 65,250 | +6.6% | 0.00% | +50.0% |
| Q4 2022 | $2,335,661 | -25.6% | 61,191 | -2.2% | 0.00% | -33.3% |
| Q3 2022 | $3,139,000 | +16.7% | 62,542 | -6.9% | 0.00% | 0.0% |
| Q2 2022 | $2,689,000 | +1.6% | 67,147 | -5.3% | 0.00% | +50.0% |
| Q1 2022 | $2,646,000 | +8.1% | 70,913 | +15.4% | 0.00% | +100.0% |
| Q4 2021 | $2,448,000 | +0.5% | 61,476 | -6.1% | 0.00% | 0.0% |
| Q3 2021 | $2,436,000 | -30.9% | 65,474 | -21.5% | 0.00% | -50.0% |
| Q2 2021 | $3,526,000 | +7.7% | 83,431 | +20.7% | 0.00% | 0.0% |
| Q1 2021 | $3,273,000 | -50.0% | 69,125 | -35.5% | 0.00% | -33.3% |
| Q4 2020 | $6,541,000 | +58.9% | 107,185 | +21.8% | 0.00% | 0.0% |
| Q3 2020 | $4,116,000 | -22.8% | 88,017 | -16.2% | 0.00% | -25.0% |
| Q2 2020 | $5,331,000 | +46.3% | 105,086 | +28.6% | 0.00% | +33.3% |
| Q1 2020 | $3,645,000 | -23.6% | 81,706 | -17.7% | 0.00% | 0.0% |
| Q4 2019 | $4,769,000 | -71.8% | 99,280 | -80.1% | 0.00% | -78.6% |
| Q3 2019 | $16,887,000 | +175.0% | 499,294 | +266.0% | 0.01% | +180.0% |
| Q2 2019 | $6,141,000 | +263.8% | 136,436 | +204.1% | 0.01% | +150.0% |
| Q1 2019 | $1,688,000 | +77.5% | 44,861 | +62.1% | 0.00% | +100.0% |
| Q4 2018 | $951,000 | -75.4% | 27,679 | -66.4% | 0.00% | -66.7% |
| Q3 2018 | $3,869,000 | +174.6% | 82,332 | +97.0% | 0.00% | +200.0% |
| Q2 2018 | $1,409,000 | -12.4% | 41,783 | -29.7% | 0.00% | 0.0% |
| Q1 2018 | $1,608,000 | +148.5% | 59,471 | +53.1% | 0.00% | 0.0% |
| Q4 2017 | $647,000 | -43.9% | 38,832 | -32.7% | 0.00% | 0.0% |
| Q3 2017 | $1,154,000 | +37.7% | 57,666 | +26.2% | 0.00% | 0.0% |
| Q2 2017 | $838,000 | -17.5% | 45,691 | -55.8% | 0.00% | 0.0% |
| Q1 2017 | $1,016,000 | +68.2% | 103,275 | +86.7% | 0.00% | 0.0% |
| Q4 2016 | $604,000 | +25.8% | 55,320 | +61.8% | 0.00% | – |
| Q3 2016 | $480,000 | +78.4% | 34,189 | -10.9% | 0.00% | – |
| Q2 2016 | $269,000 | +18.0% | 38,386 | +8.1% | 0.00% | – |
| Q1 2016 | $228,000 | -80.7% | 35,503 | -2.9% | 0.00% | -100.0% |
| Q4 2015 | $1,184,000 | -10.0% | 36,546 | -25.9% | 0.00% | -50.0% |
| Q3 2015 | $1,316,000 | -67.7% | 49,321 | -41.8% | 0.00% | -50.0% |
| Q2 2015 | $4,079,000 | -94.4% | 84,747 | -92.9% | 0.00% | -94.5% |
| Q1 2015 | $72,197,000 | +17.9% | 1,186,491 | +0.3% | 0.07% | +32.7% |
| Q4 2014 | $61,252,000 | -10.9% | 1,183,177 | -24.3% | 0.06% | -1.8% |
| Q3 2014 | $68,781,000 | +15.7% | 1,562,846 | -31.3% | 0.06% | +14.3% |
| Q2 2014 | $59,423,000 | +0.2% | 2,273,245 | +0.2% | 0.05% | -15.5% |
| Q1 2014 | $59,309,000 | +54.3% | 2,268,899 | +0.2% | 0.06% | +65.7% |
| Q4 2013 | $38,431,000 | -20.7% | 2,264,727 | +0.3% | 0.04% | -27.1% |
| Q3 2013 | $48,443,000 | – | 2,257,375 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |